Interferon–β Induces Hepatocyte Growth Factor in Monocytes of Multiple Sclerosis Patients

Interferon-β is a first-line therapy used to prevent relapses in relapsing-remitting multiple sclerosis. The clinical benefit of interferon-β in relapsing-remitting multiple sclerosis is attributed to its immunomodulatory effects on inflammatory mediators and T cell reactivity. Here, we evaluated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Molnarfi, Nicolas, Benkhoucha, Mahdia, Bjarnadóttir, Kristbjörg, Juillard, Catherine, Lalive, Patrice H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498184/
https://www.ncbi.nlm.nih.gov/pubmed/23166786
http://dx.doi.org/10.1371/journal.pone.0049882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498184/
https://www.ncbi.nlm.nih.gov/pubmed/23166786
http://dx.doi.org/10.1371/journal.pone.0049882

Ejemplares similares